| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$202,708,978 |
|
|
|
Indirect Value
|
$172,941,055 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$375,650,033 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 12 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-08 |
4 |
B |
$3.80 |
$60,754 |
D/D |
16,000 |
3,620,772 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-19 |
4 |
S |
$2.05 |
$61,078 |
I/I |
(29,723) |
10,974,532 |
0 |
% |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-21 |
4 |
S |
$3.09 |
$62,844 |
I/I |
(20,338) |
779,853 |
0 |
% |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-04-04 |
4 |
B |
$2.14 |
$64,197 |
I/I |
30,000 |
643,254 |
1.5 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-23 |
4 |
B |
$1.15 |
$65,066 |
I/I |
56,782 |
20,475,396 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-05-20 |
4 |
B |
$1.93 |
$65,376 |
I/I |
33,900 |
835,717 |
1.5 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2020-12-30 |
4 |
S |
$1.95 |
$65,783 |
I/I |
(33,697) |
11,205,637 |
0 |
% |
|
| ONCT |
Oncternal Therapeutics In... |
10% Owner |
– – • |
2010-03-12 |
4 |
B |
$3.74 |
$69,293 |
D/D |
18,518 |
3,718,779 |
2.45 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2019-03-25 |
4 |
B |
$2.31 |
$69,347 |
I/I |
30,014 |
289,066 |
1.5 |
- |
|
| BDSX |
Biodesix Inc |
|
• • • |
2023-05-25 |
4 |
B |
$1.36 |
$71,280 |
I/I |
52,508 |
20,563,212 |
0.01 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-01-15 |
4 |
S |
$2.11 |
$74,436 |
I/I |
(35,231) |
4,460,894 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-12-15 |
4 |
B |
$4.38 |
$74,679 |
I/I |
17,050 |
18,301,963 |
2.25 |
% |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2009-05-29 |
4 |
B |
$11.98 |
$75,972 |
I/I |
6,343 |
227,923 |
2.1 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-12 |
4 |
A |
$15.32 |
$76,600 |
I/I |
5,000 |
2,162,023 |
0 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
10% Owner |
– – • |
2020-02-10 |
4 |
B |
$7.91 |
$77,880 |
I/I |
9,852 |
489,496 |
1.5 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-12-09 |
4 |
A |
$15.72 |
$78,600 |
I/I |
5,000 |
2,177,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-14 |
4 |
A |
$15.75 |
$78,750 |
I/I |
5,000 |
2,167,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-12-06 |
4 |
A |
$15.94 |
$79,700 |
I/I |
5,000 |
2,172,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-13 |
4 |
A |
$16.04 |
$80,200 |
I/I |
5,000 |
1,267,023 |
0 |
- |
|
| BIOL |
Biolase Inc |
10% Owner |
– – • |
2015-11-13 |
4 |
B |
$0.86 |
$80,332 |
I/I |
93,409 |
5,815,138 |
1.5 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-03-16 |
4 |
B |
$20.55 |
$82,200 |
I/I |
4,000 |
10,761,173 |
2.25 |
- |
|
| QDEL |
QuidelOrtho Corporation |
Director |
– • – |
2006-12-13 |
4 |
S |
$13.70 |
$83,018 |
D/D |
(6,045) |
2,827,677 |
0 |
- |
|
| AWH |
Aspira Womens Health Inc |
10% Owner |
– – • |
2016-01-19 |
4 |
B |
$1.45 |
$83,736 |
I/I |
57,749 |
2,119,796 |
1.5 |
- |
|
| YTEN |
Yield10 Bioscience Inc |
|
• • • |
2022-10-17 |
4 |
S |
$3.34 |
$84,646 |
I/I |
(25,343) |
822,472 |
0 |
% |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-05-05 |
4 |
B |
$10.00 |
$86,250 |
I/I |
8,625 |
14,699,074 |
2.25 |
% |
|
634 Records found
|
|
Page 12 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
